adult
Playtime helps bind generations
Montreal, February 14, 2010 — A new study has confirmed an old adage: A family that plays together stays together. Researchers from Concordia University and Wilfrid Laurier University examined the ways grandparents can maintain close ties wi…
Human umbilical cord blood cells found to enhance survival and maturation of key brain cells
Laboratory culture (in vitro) studies examining the activity of human umbilical cord blood cells (HUCB) on experimental models of central nervous system aging, injury and disease, have shown that HUCBs provide a ‘trophic effect’ (nutritional effect)…
Homework wars: How can parents improve the odds of winning?
ANN ARBOR, Mich.—Children are more likely to do their homework if they see it as an investment, not a chore, according to new research at the University of Michigan.
Most children in the United States say they expect to go to college, but th…
Adult stem cells shown to develop into all brain cell types
Researchers at the University of Minnesota provide evidence for the first time that stem cells derived from adult bone marrow and injected into the blastocyst of a mouse can differentiate into all major types of cells found in the brain. The results of the research are published as the lead article in the April 25, 2003 issue of Cell Transplantation. The potential of these adult stem cells, termed multipotent adult progenitor cells (MAPCs), were the subject of research reported in Nature in June 2002. The research reported this week in Cell Transplantation takes a specific look at the ability of MAPCs to develop into cells typically found in the brain.
Gene signature identifies leukemia patients who should avoid transplants
An international team of researchers has used a gene test to identify certain patients with adult T-cell acute lymphoblastic leukemia (ALL) who can be successfully treated with chemotherapy alone and should not be subjected to the rigors of bone marrow transplants. The researchers found that these patients survived for at least three years after being treated with intensive chemotherapy. It was previously known that only slightly over half of the patients with this disease could be cured with chemotherapy. Adult ALL patients often undergo transplants in an effort to beat back the stubborn disease. Until now there was no way to identify those who have a more favorable outlook and shouldn’t undergo risky bone marrow transplantation.